Prediction of Atrial Fibrillation Being Asymptomatic at First Onset by Cardiac Pacing.


Journal

International heart journal
ISSN: 1349-3299
Titre abrégé: Int Heart J
Pays: Japan
ID NLM: 101244240

Informations de publication

Date de publication:
2022
Historique:
entrez: 1 6 2022
pubmed: 2 6 2022
medline: 7 6 2022
Statut: ppublish

Résumé

Asymptomatic or silent atrial fibrillation (AF) has long been a clinical problem due to the incidence of ischemic stroke. A method is needed to predict the development of silent AF before the occurrence of ischemic stroke. This study was focused on the symptoms of AF, especially palpitation, in pacemaker patients. We assessed the hypothesis that absence of palpitation during rapid ventricular pacing could be a predictor of future onset AF being asymptomatic.In this study, we assessed the presence of symptoms during RV pacing and AF symptoms on 145 pacemaker patients at the outpatient clinic by VVI pacing at 120 ppm. The relationship between symptoms during RV pacing and symptom during AF was assessed. The predictive value of absence of symptom during RV pacing on AF being asymptomatic was assessed.Of 145 patients, 74 had previous AF episode. Among the AF patients, absence of symptom during VVI pacing was associated with AF being asymptomatic.Of 145 patients, 71 had no previous AF events. There were 14 patients who had new-onset AF or atrial flutter (AFL) after the device implantation. Four of the 14 patients (28.6%) were symptomatic during first AF/AFL episode, and 10 (71.4%) were asymptomatic during first-onset AF. All ten patients who were asymptomatic during cardiac pacing test were asymptomatic during their initial episodes of AF as well.This study showed that absence of symptoms during rapid ventricular pacing was associated with first-onset AF being asymptomatic.

Identifiants

pubmed: 35650150
doi: 10.1536/ihj.21-594
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

486-491

Auteurs

Takumi J Matsubara (TJ)

Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo.

Katsuhito Fujiu (K)

Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo.
Department of Advanced Cardiology, Graduate School of Medicine, The University of Tokyo.

Satoshi Kodera (S)

Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo.

Kunihiro Kani (K)

Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo.

Kohsaku Goto (K)

Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo.

Yu Shimizu (Y)

Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo.

Gaku Oguri (G)

Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo.

Eriko Hasumi (E)

Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo.

Toshiya Kojima (T)

Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo.

Issei Komuro (I)

Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH